-
Patient-Derived Prostate Spheroids as a Translational Model
2026-09-15
Linxweiler and colleagues established viable three-dimensional spheroid cultures from organ-confined prostate cancer tissue obtained during radical prostatectomy. The model preserved key epithelial and prostate cancer markers, supported cryopreservation, and revealed differential responses to androgen-receptor-directed drugs, providing a practical platform for translational prostate cancer research.
-
Direct Mouse Genotyping Kit for Reliable PCR
2026-09-15
This scenario-based guide explains how Direct Mouse Genotyping Kit K1025 can reduce handling steps and support reproducible PCR amplification from mouse tissue before cell-based experiments. It covers experimental design, storage, controls, interpretation, and practical vendor-selection criteria for routine mouse genetic screening.
-
Lipo3K Transfection Reagent for Kidney Organoids
2026-09-14
Lipo3K Transfection Reagent combines efficient plasmid, siRNA, and mRNA delivery with a low-toxicity workflow suited to kidney organoids and difficult cell models. Its Lipo3K-A enhancer supports plasmid nuclear entry, while the reagent’s flexibility enables mechanistic rescue experiments, RNA interference research, and DNA and siRNA co-transfection without routine medium exchange.
-
DAMGO for µ-Opioid Receptor Signaling Research
2026-09-14
DAMGO enables selective interrogation of µ-opioid receptor activation across receptor-proximal assays, tissue preparations, and pain-circuit studies. This workflow-focused guide connects concentration planning and storage controls with the brain-to-spinal mechanisms underlying opioid hypersensitivity and tolerance.
-
LY294002 Workflows for PI3K Signaling Studies
2026-09-13
Build reproducible PI3K/Akt/mTOR experiments with LY294002 while separating pathway-dependent effects from concentration, timing, and BET bromodomain liabilities. This practical guide connects cancer, autophagy, and doxorubicin-induced cardiac injury models to assay-ready workflows and troubleshooting decisions.
-
Capecitabine in Tumor–Stroma Assay Workflows
2026-09-12
Capecitabine enables a practical way to study enzymatically activated fluoropyrimidine activity in organoids, assembloids, and xenograft-oriented workflows. By pairing drug response with stromal composition, thymidine phosphorylase biology, and orthogonal viability or apoptosis measurements, researchers can distinguish intrinsic sensitivity from microenvironment-mediated resistance.
-
CSBTA Pharmacokinetics in MASH: Key Insights
2026-09-12
The 2025 Biomedicine & Pharmacotherapy study shows that MASH-associated pathology changes the systemic exposure, hepatic distribution, and hepatocyte accumulation of Corydalis saxicola Bunting total alkaloids and their major constituents. By integrating UHPLC-MS/MS, transporter, microsomal metabolism, and PXR-oriented experiments, the authors identify disease-dependent enzyme and transporter changes as plausible sources of pharmacokinetic variability and dosing risk.
-
Masitinib (AB1010): KIT/PDGFR Workflow Guide
2026-09-11
Masitinib (AB1010) is a DMSO-compatible, selective tyrosine kinase inhibitor for cancer research involving KIT, PDGFRα, PDGFRβ, selected KIT-mutant models, and mast cell responses. This guide explains how to prepare and quality-control the compound while defining its limits: it is insoluble in water and ethanol and is not a substitute for clinically validated gastrointestinal stromal tumor treatment.
-
ARCA EGFP mRNA: A Smarter Transfection Control
2026-09-11
ARCA EGFP mRNA is more than a fluorescent marker: it is a practical tool for separating delivery, translation, and cell-specific expression effects. This guide explains how to use the reporter to interpret fluorescence-based transfection assays and optimize emerging lipid nanoparticle systems.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-10
The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) provides an affinity-purified rabbit IgG for detecting human, mouse, and rat HMGB1 in Western blot, frozen or paraffin immunohistochemistry, and flow cytometry. This no-paper-mode guide is based on the product dossier and practical QC controls; the reagent is for research use only and is not diagnostic, therapeutic, or clinically validated.
-
GM 6001: From MMP Biology to Translation
2026-09-10
GM 6001 (Galardin) offers translational researchers a practical way to test whether matrix metalloproteinase-driven extracellular matrix remodeling is causal in disease phenotypes. This article connects perineuronal-net preservation in Alzheimer’s disease models with assay strategy, meniscal healing research, EGFR transactivation inhibition, cancer cell proliferation modulation, and vascular smooth muscle cell migration inhibition—while defining the limits of broad-spectrum pharmacology.
-
Ruxolitinib Workflows for JAK-STAT Research
2026-09-09
Build reproducible Ruxolitinib assays that connect biochemical JAK1/JAK2 inhibition with phospho-signaling, progenitor growth, and immune-cell readouts. This workflow also adapts a neonatal monocyte inflammation model while clearly separating TLR4-proximal effects from downstream JAK-STAT signaling.
-
Trelagliptin, RUNX2, and Osteoblast Differentiation
2026-09-09
The reference study identifies an osteogenic activity of trelagliptin in MC3T3-E1 cells, linking enhanced mineralization and osteoblast-marker expression to RUNX2 and AMPK signaling. Its findings extend investigation of this long-acting DPP-4 inhibitor beyond glycemic biology while remaining limited to an in vitro model that requires validation in primary cells and osteoporosis models.
-
Imipramine: A Translational Autophagy Strategy
2026-09-08
Imipramine can serve as a research bridge between transporter pharmacology, autophagy, apoptosis, and lipid metabolism. This thought-leadership article translates ceramide-centered virology findings into bounded, mechanism-focused workflows for glioma, leukemia, neuroscience, and immunology research.
-
Tiamulin (Thiamutilin): From Ribosome to Translation
2026-09-08
Tiamulin is more than a veterinary pleuromutilin antibiotic: it is a mechanistically distinctive tool for connecting bacterial translation, inflammatory signaling, pharmacokinetics, and residue science. This thought-leadership guide shows how translational researchers can use Tiamulin (Thiamutilin) to design stronger infection and inflammation studies while accounting for species-specific metabolism, exposure, formulation, and the limits of cross-domain interpretation.